We are live on ! Find out more
CW

Cabot-Wellington Portfolio holdings

AUM $380M
1-Year Est. Return 21.78%
This Fund
S&P 500
This Quarter Est. Return
+3.73%
1 Year Est. Return
+21.78%
3 Year Est. Return
+64.98%
5 Year Est. Return
+59.32%
10 Year Est. Return
+170.75%
AUM
$115M
AUM Growth
-$20.7M
Cap. Flow
-$21.7M
Cap. Flow %
-18.88%
Top 10 Hldgs %
96.41%
Holding
23
New
1
Increased
1
Reduced
13
Closed
5

Top Buys

Rank Stock Value
1
COKE icon
Coca-Cola Consolidated
COKE
+$5.78M
2
VTI icon
Vanguard Morningstar Total Stock Market ETF
VTI
+$2.06M

Top Sells

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$12.8M
2
ABT icon
Abbott
ABT
+$6.91M
3
AAPL icon
Apple
AAPL
+$3.84M
4
MON
Monsanto Co
MON
+$3.5M
5
GE icon
GE Aerospace
GE
+$745K

Sector Composition

Rank Sector Weight
1 Energy 35.67%
2 Healthcare 19.84%
3 Materials 16.56%
4 Financials 12.96%
5 Communication Services 8.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CTRA
1
DELISTED
Coterra Energy
CTRA
$23.8M 20.69%
951,778
-7,245
-0.8% -$174K
CBT icon
2
Cabot Corp
CBT
$4.54B
$19M 16.56%
388,765
-3,910
-1% -$182K
GILD icon
3
Gilead Sciences
GILD
$162B
$11.8M 10.26%
147,903
-5,100
-3% -$453K
JPM icon
4
JPMorgan Chase
JPM
$938B
$10.4M 9.06%
157,630
-1,805
-1% -$113K
SYK icon
5
Stryker
SYK
$125B
$10.1M 8.81%
88,261
-1,695
-2% -$190K
GOOGL icon
6
Alphabet (Google) Class A
GOOGL
$4.34T
$9.25M 8.05%
229,780
-4,300
-2% -$158K
MMP
7
DELISTED
Magellan Midstream Partners, L.P.
MMP
$8.88M 7.72%
126,141
-1,400
-1% -$99.3K
EPD icon
8
Enterprise Products Partners
EPD
$81.9B
$8.35M 7.26%
303,000
-2,800
-0.9% -$75.2K
VTI icon
9
Vanguard Morningstar Total Stock Market ETF
VTI
$660B
$4.7M 4.09%
42,051
+19,485
+86% +$2.06M
STT icon
10
State Street
STT
$50.6B
$4.49M 3.9%
65,824
-350
-0.5% -$20.9K
COKE icon
11
Coca-Cola Consolidated
COKE
$12.5B
$1.72M 1.49%
+395,540
New +$5.78M
JNJ icon
12
Johnson & Johnson
JNJ
$622B
$575K 0.5%
4,650
-300
-6% -$34.1K
MMM icon
13
3M
MMM
$90.7B
$363K 0.32%
2,428
– –
IVV icon
14
iShares Core S&P 500 ETF
IVV
$877B
$356K 0.31%
1,625
– –
PFE icon
15
Pfizer
PFE
$143B
$314K 0.27%
9,486
-3,162
-25% -$101K
HON icon
16
Honeywell
HON
$77.5B
$306K 0.27%
2,938
-223
-7% -$22.9K
FDX icon
17
FedEx
FDX
$73B
$278K 0.24%
1,700
– –
SPY icon
18
State Street SPDR S&P 500 ETF Trust
SPY
$789B
$223K 0.19%
1,022
-625
-38% -$130K
AAPL icon
19
Apple
AAPL
$4.45T
– –
-140,860
Closed -$3.84M
ABT icon
20
Abbott
ABT
$183B
– –
-165,135
Closed -$6.91M
CVS icon
21
CVS Health
CVS
$134B
– –
-123,522
Closed -$12.8M
GE icon
22
GE Aerospace
GE
$374B
– –
-4,893
Closed -$745K
MON
23
DELISTED
Monsanto Co
MON
– –
-39,885
Closed -$3.5M

Similar funds

AC
Attestor Capital Grand Cayman, Cayman Islands $380M AUM
EAM
Empirical Asset Management Wellesley, Massachusetts $379M AUM 24.52% 1-Year Est. Return
MC
Muhlenkamp & Co Wexford, Pennsylvania $380M AUM 43.74% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $379M AUM 28.34% 1-Year Est. Return
KFS
Kurt F. Somerville $379M AUM 19.42% 1-Year Est. Return
CFG
Carr Financial Group Worcester, Massachusetts $379M AUM 21.34% 1-Year Est. Return
PIM
Progressive Investment Management Lake Oswego, Oregon $379M AUM 24.17% 1-Year Est. Return
AWA
Aquire Wealth Advisors South Jordan, Utah $381M AUM 17.5% 1-Year Est. Return

Cabot-Wellington's Q2 2016 Portfolio in Review

As of Q2 2016, Cabot-Wellington held 23 positions worth $115M, down 15% from $136M the previous quarter. Its ten largest holdings account for 96% of the portfolio.

Cabot-Wellington withdrew a net $21.7M in Q2 2016, closing 5 positions and reducing 13 holdings. Its most notable exit was CVS Health, an estimated $12.8M position sold in full.

By sector, the portfolio is most concentrated in Energy at 36% of assets, up from 28% a quarter earlier, followed by Healthcare and Materials.

Against the trend, Cabot-Wellington opened a new position in Coca-Cola Consolidated worth $1.72M.

  • Cabot-Wellington's largest Q2 2016 buy was Coca-Cola Consolidated: 395,540 shares worth $1.72M.
  • Cabot-Wellington added most to Vanguard Morningstar Total Stock Market ETF in Q2 2016, an estimated $2.06M increase.
  • Cabot-Wellington's biggest Q2 2016 reduction was Gilead Sciences, cutting an estimated $453K.
  • Cabot-Wellington fully exited CVS Health in Q2 2016, selling an estimated $12.8M.
  • Cabot-Wellington's ten largest holdings make up 96% of its $115M portfolio in Q2 2016.
  • Cabot-Wellington opened 1 new position and closed 5 in Q2 2016.
  • Cabot-Wellington's portfolio value fell 15% quarter-over-quarter to $115M.

Based on Cabot-Wellington's 13F filing for Q2 2016, filed 9 Aug 2016.